Previous 10 | Next 10 |
Shares of the Chinese anti-cancer cell therapy specialist Legend Biotech (NASDAQ: LEGN) are poised for a rough session today. Ahead of the opening bell Monday morning, the biotech's stock fell by as much as 15.8% in response to the news that the Customs Anti-Smuggling Department of ...
Legend Biotech (LEGN) appoints Dr. Ying Huang as interim CEO, effective immediately in addition to his current position of CFO.Dr. Zhang remains Chairman of the Board of Directors of Legend Biotech.In connection with the investigation, relating to suspected violations of import and export reg...
Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global, clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, today announced that its Board of Directors has appointed D...
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, will participate in the 18 th Annual Morgan Stanley Virtual Global Healthcare Con...
Legend Biotech (NASDAQ: LEGN ) : Q2 GAAP EPS of -$0.63 misses by $0.42 . More news on: Legend Biotech Corporation, Earnings news and commentary, Read more ...
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, today reported financial results for the quarter ended June 30, 2020. “...
First investigational product being recommended for Breakthrough Therapy Designation in China Legend Biotech Corporation (NASDAQ:LEGN) announced today that the China Center for Drug Evaluation, National Medical Products Administration (CDE, NMPA) has recommended Breakthrough Therapy ...
For 1H20 , Legend Biotech ( LEGN -3.8% ) estimated loss from continuous operations of ~$89-$103M including R&D expenses of ~$96.5M-$111.8M. More news on: Legend Biotech Corporation, Healthcare stocks news, Stocks on the move, Read more ...
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, today announced that its Board of Directors has appointed Dr. Frank Zhang to serve...
Legend Biotech (NASDAQ: LEGN) today announced preliminary results for the first half of 2020. For the six months ended June 30, 2020, Legend Biotech expects to record a loss from approximately US$89.0 million to US$103.0 million from continuous operations (before one-time charges, includi...
News, Short Squeeze, Breakout and More Instantly...
Legend Biotech Corporation Company Name:
LEGN Stock Symbol:
NASDAQ Market:
Legend Biotech Corporation Website:
SOMERSET, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Friday, August 9, 2024, to review second-quarter 2024 results. During the webcast and confe...
SOMERSET, N.J., July 02, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today positive overall survival results from CARTITUDE-4, an ongoing, global randomized, open-label Phase 3 study evaluating the efficacy and sa...
2024-06-20 17:01:11 ET USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 20,2024 – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number o...